Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1 GBP
152.85 M GBP
2.31 B GBP
158.10 M
About HIKMA PHARMACEUTICALS ORD GBP0.10
Sector
CEO
Riad Mishlawi
Headquarters
London
Website
Founded
1978
ISIN
GB00B0LCW083
FIGI
BBG000FG1MF1
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment sells branded generics and in-licensed patented products in the Middle East and North Africa. The Injectables segment includes generic injectable products distributed globally and primarily used in hospitals. The Generics segment focuses on oral and other non-injectable generic products, and is sold in the U.S. retail market. The Others segment comprises of Arab Medical Containers Ltd., International Pharmaceutical Research Center Ltd., and the chemicals division of Hikma Pharmaceuticals Ltd. (Jordan). The company was founded by Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.
Is this Hikma's cue for a break out?Will Hikma break out after a 5 year H&S pattern,
now that it's making progress in the Covid-19 vaccine business?
Hikma Pharmaceuticals - Injecting some bullish momentum.Buy Hikma Pharmaceuticals (HIK.L)
Hikma Pharmaceuticals PLC develops, manufactures, and markets pharmaceutical products. The Company offers branded and non-branded generic and in-licensed pharmaceutical products. Hikma Pharmaceuticals serves customers worldwide.
Market Cap: £4.79Billion
The lo
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HIK is 1,859 GBX — it has increased by 0.38% in the past 24 hours. Watch HIKMA PHARMACEUTICALS ORD GBP0.10 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HIKMA PHARMACEUTICALS ORD GBP0.10 stocks are traded under the ticker HIK.
HIK stock has risen by 0.76% compared to the previous week, the month change is a −8.21% fall, over the last year HIKMA PHARMACEUTICALS ORD GBP0.10 has showed a 5.69% increase.
We've gathered analysts' opinions on HIKMA PHARMACEUTICALS ORD GBP0.10 future price: according to them, HIK price has a max estimate of 2,819.30 GBX and a min estimate of 1,992.11 GBX. Watch HIK chart and read a more detailed HIKMA PHARMACEUTICALS ORD GBP0.10 stock forecast: see what analysts think of HIKMA PHARMACEUTICALS ORD GBP0.10 and suggest that you do with its stocks.
HIK stock is 2.31% volatile and has beta coefficient of 0.67. Track HIKMA PHARMACEUTICALS ORD GBP0.10 stock price on the chart and check out the list of the most volatile stocks — is HIKMA PHARMACEUTICALS ORD GBP0.10 there?
Today HIKMA PHARMACEUTICALS ORD GBP0.10 has the market capitalization of 4.08 B, it has increased by 2.84% over the last week.
Yes, you can track HIKMA PHARMACEUTICALS ORD GBP0.10 financials in yearly and quarterly reports right on TradingView.
HIKMA PHARMACEUTICALS ORD GBP0.10 is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
HIKMA PHARMACEUTICALS ORD GBP0.10 revenue for the last half-year amounts to 1.24 B GBX, despite the estimated figure of 1.19 B GBX. In the next half-year revenue is expected to reach 1.21 B GBX.
HIK net income for the last half-year is 178.69 M GBP, while the previous report showed 47.09 M GBP of net income which accounts for 279.48% change. Track more HIKMA PHARMACEUTICALS ORD GBP0.10 financial stats to get the full picture.
HIKMA PHARMACEUTICALS ORD GBP0.10 dividend yield was 3.17% in 2023, and payout ratio reached 81.97%. The year before the numbers were 2.92% and 66.56% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 9.10 K employees. See our rating of the largest employees — is HIKMA PHARMACEUTICALS ORD GBP0.10 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HIKMA PHARMACEUTICALS ORD GBP0.10 EBITDA is 544.82 M GBP, and current EBITDA margin is 23.72%. See more stats in HIKMA PHARMACEUTICALS ORD GBP0.10 financial statements.
Like other stocks, HIK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HIKMA PHARMACEUTICALS ORD GBP0.10 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HIKMA PHARMACEUTICALS ORD GBP0.10 technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HIKMA PHARMACEUTICALS ORD GBP0.10 stock shows the sell signal. See more of HIKMA PHARMACEUTICALS ORD GBP0.10 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.